Political Costs and Accounting Method Choice: The Pharmaceutical Industry
This study examines the validity of positive accounting research by calculating the net income effect of accounting and managerial choices within the pharmaceutical industry. The overall results support the positive accounting theory. The accounting choices of larger firms showed a net negative inco...
Gespeichert in:
| Veröffentlicht in: | The Mid-Atlantic journal of business 2000-12, Vol.36 (4), p.193 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 193 |
| container_title | The Mid-Atlantic journal of business |
| container_volume | 36 |
| creator | MEYER, MICHAEL J KARIM, KHONDKAR E GARA, STEPHEN C |
| description | This study examines the validity of positive accounting research by calculating the net income effect of accounting and managerial choices within the pharmaceutical industry. The overall results support the positive accounting theory. The accounting choices of larger firms showed a net negative income effect. In contrast, the accounting choices of smaller firms had a less net negative or even a net positive effect. The political variables specific to the industry, with the exception of 2, were all significant in the hypothesized direction. When the 3 significant political variables were linearly combined using factor analysis, the resulting political factor was highly significant in explaining the effect of accounting and managerial choices. |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_203738861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A74524606</galeid><sourcerecordid>A74524606</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1021-e746d1405bf640c02825796ab2e9b9b14999d37531e951c1f2ce1c0582b00aed3</originalsourceid><addsrcrecordid>eNptzT1PwzAQBuAMIFEK_8FiJpI_k5gtivioVESHMkeOfUlcpTbYzsC_J1LY6N1w0qvn7q6yDS4ZzSVj_Ca7jfGElxKs2mS7g59sslpNqPExRaScQbXWfnbJugG9Qxq9Qc3orYYndBwBHUYVzkrDvK7tnJljCj932XWvpgj3f3Obfb48H5u3fP_xumvqfT4QTEkOJS8M4Vh0fcGxxrSiopSF6ijITnaESykNKwUjIAXRpKcaiMaioh3GCgzbZg_r3a_gv2eIqT35ObjlZUsxK1lVFWRBjysa1AStdb1PQekBHAQ1eQe9XeK65ILyAhcLzy_wpQ2crf7vfwEOgGUe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>203738861</pqid></control><display><type>article</type><title>Political Costs and Accounting Method Choice: The Pharmaceutical Industry</title><source>Alma/SFX Local Collection</source><creator>MEYER, MICHAEL J ; KARIM, KHONDKAR E ; GARA, STEPHEN C</creator><creatorcontrib>MEYER, MICHAEL J ; KARIM, KHONDKAR E ; GARA, STEPHEN C</creatorcontrib><description>This study examines the validity of positive accounting research by calculating the net income effect of accounting and managerial choices within the pharmaceutical industry. The overall results support the positive accounting theory. The accounting choices of larger firms showed a net negative income effect. In contrast, the accounting choices of smaller firms had a less net negative or even a net positive effect. The political variables specific to the industry, with the exception of 2, were all significant in the hypothesized direction. When the 3 significant political variables were linearly combined using factor analysis, the resulting political factor was highly significant in explaining the effect of accounting and managerial choices.</description><identifier>ISSN: 0732-9334</identifier><language>eng</language><publisher>South Orange: Stillman School of Business</publisher><subject>Accounting ; Accounting and auditing ; Accounting policies ; Accounting procedures ; Accounting theory ; Costs ; Decision making ; Defined benefit plans ; Discriminant analysis ; Drugs ; Financial accounting standards ; Net income ; Pharmaceutical industry ; R&D ; Research & development ; Research methodology ; Studies ; Useful life ; Variables</subject><ispartof>The Mid-Atlantic journal of business, 2000-12, Vol.36 (4), p.193</ispartof><rights>COPYRIGHT 2000 Stillman School of Business</rights><rights>Copyright Seton Hall University, School of Business Administration Dec 2000</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids></links><search><creatorcontrib>MEYER, MICHAEL J</creatorcontrib><creatorcontrib>KARIM, KHONDKAR E</creatorcontrib><creatorcontrib>GARA, STEPHEN C</creatorcontrib><title>Political Costs and Accounting Method Choice: The Pharmaceutical Industry</title><title>The Mid-Atlantic journal of business</title><description>This study examines the validity of positive accounting research by calculating the net income effect of accounting and managerial choices within the pharmaceutical industry. The overall results support the positive accounting theory. The accounting choices of larger firms showed a net negative income effect. In contrast, the accounting choices of smaller firms had a less net negative or even a net positive effect. The political variables specific to the industry, with the exception of 2, were all significant in the hypothesized direction. When the 3 significant political variables were linearly combined using factor analysis, the resulting political factor was highly significant in explaining the effect of accounting and managerial choices.</description><subject>Accounting</subject><subject>Accounting and auditing</subject><subject>Accounting policies</subject><subject>Accounting procedures</subject><subject>Accounting theory</subject><subject>Costs</subject><subject>Decision making</subject><subject>Defined benefit plans</subject><subject>Discriminant analysis</subject><subject>Drugs</subject><subject>Financial accounting standards</subject><subject>Net income</subject><subject>Pharmaceutical industry</subject><subject>R&D</subject><subject>Research & development</subject><subject>Research methodology</subject><subject>Studies</subject><subject>Useful life</subject><subject>Variables</subject><issn>0732-9334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptzT1PwzAQBuAMIFEK_8FiJpI_k5gtivioVESHMkeOfUlcpTbYzsC_J1LY6N1w0qvn7q6yDS4ZzSVj_Ca7jfGElxKs2mS7g59sslpNqPExRaScQbXWfnbJugG9Qxq9Qc3orYYndBwBHUYVzkrDvK7tnJljCj932XWvpgj3f3Obfb48H5u3fP_xumvqfT4QTEkOJS8M4Vh0fcGxxrSiopSF6ijITnaESykNKwUjIAXRpKcaiMaioh3GCgzbZg_r3a_gv2eIqT35ObjlZUsxK1lVFWRBjysa1AStdb1PQekBHAQ1eQe9XeK65ILyAhcLzy_wpQ2crf7vfwEOgGUe</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>MEYER, MICHAEL J</creator><creator>KARIM, KHONDKAR E</creator><creator>GARA, STEPHEN C</creator><general>Stillman School of Business</general><general>Seton Hall University, School of Business Administration</general><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7WY</scope><scope>7WZ</scope><scope>7XB</scope><scope>87Z</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>F~G</scope><scope>K60</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYYUZ</scope><scope>Q9U</scope></search><sort><creationdate>20001201</creationdate><title>Political Costs and Accounting Method Choice: The Pharmaceutical Industry</title><author>MEYER, MICHAEL J ; KARIM, KHONDKAR E ; GARA, STEPHEN C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1021-e746d1405bf640c02825796ab2e9b9b14999d37531e951c1f2ce1c0582b00aed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Accounting</topic><topic>Accounting and auditing</topic><topic>Accounting policies</topic><topic>Accounting procedures</topic><topic>Accounting theory</topic><topic>Costs</topic><topic>Decision making</topic><topic>Defined benefit plans</topic><topic>Discriminant analysis</topic><topic>Drugs</topic><topic>Financial accounting standards</topic><topic>Net income</topic><topic>Pharmaceutical industry</topic><topic>R&D</topic><topic>Research & development</topic><topic>Research methodology</topic><topic>Studies</topic><topic>Useful life</topic><topic>Variables</topic><toplevel>online_resources</toplevel><creatorcontrib>MEYER, MICHAEL J</creatorcontrib><creatorcontrib>KARIM, KHONDKAR E</creatorcontrib><creatorcontrib>GARA, STEPHEN C</creatorcontrib><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><jtitle>The Mid-Atlantic journal of business</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MEYER, MICHAEL J</au><au>KARIM, KHONDKAR E</au><au>GARA, STEPHEN C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Political Costs and Accounting Method Choice: The Pharmaceutical Industry</atitle><jtitle>The Mid-Atlantic journal of business</jtitle><date>2000-12-01</date><risdate>2000</risdate><volume>36</volume><issue>4</issue><spage>193</spage><pages>193-</pages><issn>0732-9334</issn><abstract>This study examines the validity of positive accounting research by calculating the net income effect of accounting and managerial choices within the pharmaceutical industry. The overall results support the positive accounting theory. The accounting choices of larger firms showed a net negative income effect. In contrast, the accounting choices of smaller firms had a less net negative or even a net positive effect. The political variables specific to the industry, with the exception of 2, were all significant in the hypothesized direction. When the 3 significant political variables were linearly combined using factor analysis, the resulting political factor was highly significant in explaining the effect of accounting and managerial choices.</abstract><cop>South Orange</cop><pub>Stillman School of Business</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-9334 |
| ispartof | The Mid-Atlantic journal of business, 2000-12, Vol.36 (4), p.193 |
| issn | 0732-9334 |
| language | eng |
| recordid | cdi_proquest_journals_203738861 |
| source | Alma/SFX Local Collection |
| subjects | Accounting Accounting and auditing Accounting policies Accounting procedures Accounting theory Costs Decision making Defined benefit plans Discriminant analysis Drugs Financial accounting standards Net income Pharmaceutical industry R&D Research & development Research methodology Studies Useful life Variables |
| title | Political Costs and Accounting Method Choice: The Pharmaceutical Industry |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A14%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Political%20Costs%20and%20Accounting%20Method%20Choice:%20The%20Pharmaceutical%20Industry&rft.jtitle=The%20Mid-Atlantic%20journal%20of%20business&rft.au=MEYER,%20MICHAEL%20J&rft.date=2000-12-01&rft.volume=36&rft.issue=4&rft.spage=193&rft.pages=193-&rft.issn=0732-9334&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA74524606%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=203738861&rft_id=info:pmid/&rft_galeid=A74524606&rfr_iscdi=true |